Susquehanna International Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-140,618
| Closed | -$12M | – | 12104 |
|
|
2020
Q3 | $12M | Sell |
140,618
-35,568
| -20% | -$1.8M | ﹤0.01% | 1981 |
|
|
2020
Q2 | $6.24M | Sell |
176,186
-403,025
| -70% | -$11.8M | ﹤0.01% | 2704 |
|
|
2020
Q1 | $7.81M | Buy |
579,211
+337,788
| +140% | +$5.68M | ﹤0.01% | 2040 |
|
|
2019
Q4 | $5.11M | Sell |
241,423
-173,368
| -42% | -$3.06M | ﹤0.01% | 2939 |
|
|
2019
Q3 | $5.5M | Buy |
414,791
+25,164
| +6% | +$370K | ﹤0.01% | 2603 |
|
|
2019
Q2 | $5.4M | Buy |
389,627
+352,845
| +959% | +$5.31M | ﹤0.01% | 2611 |
|
|
2019
Q1 | $707K | Sell |
36,782
-1,534,655
| -98% | -$24.7M | ﹤0.01% | 5659 |
|
|
2018
Q4 | $22.4M | Buy |
1,571,437
+255,185
| +19% | +$5.07M | 0.01% | 1002 |
|
|
2018
Q3 | $27.4M | Buy |
1,316,252
+146,343
| +13% | +$3.47M | 0.01% | 1078 |
|
|
2018
Q2 | $27.7M | Buy |
1,169,909
+409,428
| +54% | +$8.23M | 0.01% | 1050 |
|
|
2018
Q1 | $11.1M | Buy |
760,481
+361,209
| +90% | +$5.9M | ﹤0.01% | 1684 |
|
|
2017
Q4 | $6.45M | Buy |
399,272
+310,813
| +351% | +$3.67M | ﹤0.01% | 2256 |
|
|
2017
Q3 | $1.24M | Buy |
+88,459
| New | +$882K | ﹤0.01% | 4869 |
|
|
2017
Q1 | – | Sell |
-505,422
| Closed | -$2.56M | – | 10420 |
|
|
2016
Q4 | $1.85M | Buy |
505,422
+305,981
| +153% | +$905K | ﹤0.01% | 4226 |
|
|
2016
Q3 | $648K | Sell |
199,441
-128,888
| -39% | -$360K | ﹤0.01% | 5580 |
|
|
2016
Q2 | $762K | Buy |
+328,329
| New | +$1.1M | ﹤0.01% | 5388 |
|
|
2016
Q1 | – | Sell |
-252,109
| Closed | -$567K | – | 9958 |
|
|
2015
Q4 | $774K | Buy |
252,109
+37,185
| +17% | +$104K | ﹤0.01% | 5938 |
|
|
2015
Q3 | $370K | Sell |
214,924
-6,241
| -3% | -$15.9K | ﹤0.01% | 7669 |
|
|
2015
Q2 | $898K | Sell |
221,165
-13,216
| -6% | -$54K | ﹤0.01% | 6445 |
|
|
2015
Q1 | $898K | Sell |
234,381
-66,943
| -22% | -$291K | ﹤0.01% | 5969 |
|
|
2014
Q4 | $1.45M | Buy |
301,324
+1,282
| +0.4% | +$5.07K | ﹤0.01% | 5104 |
|
|
2014
Q3 | $1.12M | Sell |
300,042
-197,657
| -40% | -$668K | ﹤0.01% | 5722 |
|
|
2014
Q2 | $1.82M | Buy |
497,699
+132,648
| +36% | +$487K | ﹤0.01% | 4850 |
|
|
2014
Q1 | $1.54M | Sell |
365,051
-258,492
| -41% | -$1.28M | ﹤0.01% | 4758 |
|
|
2013
Q4 | $2.87M | Buy |
623,543
+324,147
| +108% | +$1.44M | ﹤0.01% | 3712 |
|
|
2013
Q3 | $1.85M | Sell |
299,396
-186,228
| -38% | -$1.07M | ﹤0.01% | 4215 |
|
|
2013
Q2 | $2.64M | Buy |
+485,624
| New | +$1.6M | ﹤0.01% | 3466 |
|
Susquehanna International Group's IMMU Position: Q4 2020 in Review
Susquehanna International Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 140,618 shares — an estimated $12M sold.
Susquehanna International Group first reported a position in IMMU in Q2 2013 and held it in 27 quarters. The position peaked at $27.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Susquehanna International Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Susquehanna International Group sold 140,618 Immunomedics Inc shares in Q4 2020, an estimated $12M.
- Susquehanna International Group first reported a position in Immunomedics Inc in Q2 2013 and held it in 27 quarters.
- Susquehanna International Group's Immunomedics Inc position peaked at $27.7M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.